This CX Programme is subject to change.
CX Vascular Malformations - Wednesday, 17th April
Venue: London Room Learning Centre
Time: 13:30 - 18:00
Introduction
Time: 13:30 - 13:32
| Speaker: | Fiona Rohlffs, Hamburg, Germany |
Basic background and imaging
Time: 13:32 - 14:00
| Chairing: | Fiona Rohlffs, Hamburg, Germany |
| Moderator: | Ian McCafferty, Birmingham, United Kingdom |
13:32 - 13:40
ISSVA classification and what recent genetics can teach us in the management of VMs
| Speaker: | Laurence Boon, Brussels, Belgium |
13:40 - 13:48
The need for a classification system in the treatment of high-flow VMs
| Speaker: | Fiona Rohlffs, Hamburg, Germany |
13:48 - 13:56
Finding a useful classification for the treatment of low-flow VMs
| Speaker: | Jocelyn Brookes, London, United Kingdom |
13:56 - 14:00
Audience participation and discussion
Low-flow malformations
Time: 14:00 - 14:56
| Chairing: | Walter Wohlgemuth, Regensburg, Germany |
| Moderator: | Wayne Yakes, Englewood, United States |
14:00 - 14:08
Management of low-flow VMs - technique and materials
| Speaker: | Walter Wohlgemuth, Regensburg, Germany |
14:08 - 14:16
Results and long follow-up of treatment of low-flow VMs
| Speaker: | Ian McCafferty, Birmingham, United Kingdom |
14:16 - 14:24
Intraosseous vascular malformations
| Speaker: | Fiona Rohlffs, Hamburg, Germany |
14:24 - 14:32
Egyptian experience with capillary venous malformations
| Speaker: | Tarek Radwan, Cairo, Egypt |
14:32 - 14:40
Managing dangerous communications in low flow malformations - how to avoid disasters!
| Speaker: | Robert Vogelzang, Chicago, United States |
14:40 - 14:48
Extreme and complex venous lymphatic low-flow VM - results
| Speaker: | Wayne Yakes, Englewood, United States |
14:48 - 14:56
Patient radiation exposure from embolo-sclerotherapy of vascular malformations
| Speaker: | Leeying Giet, London, United Kingdom |
Debate
Time: 14:56 - 15:30
| Chairing: | Fiona Rohlffs, Hamburg, Germany |
| Moderator: | Laurence Boon, Brussels, Belgium |
14:56 - 15:20
How do we define "cure" in low-flow VMs? Can we actually "cure them" - Yes/No?
15:20 - 15:28
Rebuttal: 2 min/participant
15:24 - 15:30
Conclusion and vote
Tea break
Time: 15:30 - 16:00
High-flow malformations
Time: 16:00 - 16:24
| Chairing: | Robert Vogelzang, Chicago, United States |
| Moderator: | Wayne Yakes, Englewood, United States |
16:00 - 16:08
Failure to control symptomatic AVMs using polymerizing agents, salvaged by alcohol embolotherapy
| Speaker: | Robert Vogelzang, Chicago, United States |
16:08 - 16:16
Management of extreme AVMs
| Speaker: | Wayne Yakes, Englewood, United States |
16:16 - 16:24
Outcomes and follow-up of treatment of AVMs
| Speaker: | Robert Vogelzang, Chicago, United States |
Imaging
Time: 16:24 - 16:32
16:24 - 16:32
Imaging: pre- and post-treatment of VMs
| Speaker: | Alex Barnacle, London, United Kingdom |
The complimentary role of surgery in VMs
Time: 16:32 - 16:48
| Chairing: | Robert Vogelzang, Chicago, United States |
| Moderator: | Wayne Yakes, Englewood, United States |
16:32 - 16:40
Deciding whether surgery and rapamycine are friends or enemies
| Speaker: | Laurence Boon, Brussels, Belgium |
16:40 - 16:48
Surgical management of arteriovenous malformation
| Speaker: | Laurence Boon, Brussels, Belgium |
Case presentations: Help, I am stuck!!
Summary and closing remarks
Time: 17:48 - 18:00
| Speaker: | Wayne Yakes, Englewood, United States |